Metabolomics Core Facility

Leadership

Dr. Hamid Baniasadi portrait
Dr. Hamid Baniasadi
Assistant Professor, Director of Metabolomics Core Facility

Biography

Hamid Baniasadi, Ph.D., is an Assistant Professor in the Department of Biochemistry at the University of Texas Southwestern Medical Center, as well as the Director of Metabolomics Core Facility within the Biochemistry Department.

Dr. Baniasadi holds a bachelor's degree in chemistry from Kerman University, Iran. He earned a master's degree in chemistry from the Ball State University, Muncie, IN. Hamid received his Ph.D. degree in analytical chemistry from Purdue University, West Lafayette IN, and completed his postdoctoral training at the University of Minnesota, Minneapolis, MN.

His Ph.D. research focused on the development and application of mass spectrometry based metabolomics for the discovery of disease biomarkers. Dr. Baniasadi has extensive experience over the past 14+ years with MS based metabolomics studies, including targeted and untargeted (global) metabolite analysis using various types of mass spectrometers including: GC-MS, LC-MS (linear ion trap), LC-MS/MS (triple quadrupole) and LC-TOF-MS. He joined the faculty of the University of Texas Southwestern Medical Center in 2017.

Education

  • Doctorate of Philosophy in Analytical Chemistry, Purdue University, West Lafayette, IN (2013)
  • Master of Science in Chemistry, Ball State University, Muncie, IN (2008)
  • Master of Science in Chemistry, Birjand University, Iran (2000)
  • Bachelor of Science, Kerman University, Iran (1994)
  • Postdoctoral Associate at the Masonic Cancer Center, University of Minnesota, Minneapolis, MN (2013-2015)

Research Interests

  • LC-MS and LC-MS/MS Methods development
  • Biomarker discovery based on metabolomics research
  • Targeted and untargeted metabolomics
  • Cancer and Metabolism

Professional Associations/Affiliations

  • American Society for Mass Spectrometry
  • American Chemical Society
  • Metabolomics Society

Publications

  1. Mayur Doke, Jay P. McLaughlin, Hamid Baniasadi, Thangavel Samikkannu, “Sleep Disorder and Cocaine Abuse Impact Purine and Pyrimidine Nucleotide Metabolic Signatures”, Metabolites 2022, 12, 869.
  2. Fernando H. Martins, Anubama Rajanc, Hannah E. Carterc, Hamid R. Baniasadi, Anthony W. Maresso, Vanessa Sperandio, “Interactions between Enterohemorrhagic Escherichia coli (EHEC) and Gut Commensals at the Interface of Human Colonoids”, mBio. 2022 Jun 28;13(3):e0132122.
  3. Xue J, Han Y, Baniasadi H, Zeng W, Pei J, Grishin NV, Wang J, Tu BP, Jiang Y. “TMEM120A is a coenzyme A-binding membrane protein with structural similarities to ELOVL fatty acid elongase” Elife. 2021 Aug 10; 10: e71220.
  4. Junjie Li, Diana Canseco, Yuzhu Wang, Goncalo Dias do Vale, Jaideep Chaudhary, Arnida Anwar, Hamid Baniasadi, Benjamin Tu, Noelle Williams, Purva Gopal, Patrick Sutphin, Jeffrey G. McDonald, William C. Putnam and Ian R. Corbin, “Assessing the Safety of Transarterial Locoregional Delivery of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles to the Rat Liver”, Eur J Pharm Biopharm . 2021 Jan;158:273-283.
  5. Rilee D. Zeinert, Hamid Baniasadi, Benjamin Tu, Peter Chien, “Lon protease links nucleotide metabolism with proteotoxic stress”, Mol Cell . 2020 Sep 3;79(5):758-767.
  6. B. Xi, H. Gu, H. R. Baniasadi, Daniel Raftery, “Statistical Analysis and Modeling of Mass Spectrometry-Based Metabolomics Data” Chapter 22, Mass Spectrometry in Metabolomics, Methods in Molecular Biology Volume 1198, 2014, pp 333-353, Springer New York.
  7. H. R. Baniasadi, C. Vlahakis, J. Hazebroek, C. Zhong, V. Asiago, “The Effect of Genetics and Environment on the Metabolome of Commercial Maize Hybrids Using LC/MS: A Multisite Study” Journal of Agricultural and Food Chemistry, 2014, 62 (6), 1412-1422.
  8. H. R. Baniasadi, G. A. Nagana Gowda, A. Zeng, S. Zhuang, M. Maluccio, D. Raftery, “Targeted Metabolic Profiling of Hepatocellular Carcinoma and Hepatitis C using LC-MS/MS” Electrophoresis. 2013, 1–8.
  9. D. Djukovic, H. R. Baniasadi, R. K, Z. Hammoud, D. Raftery, “Targeted serum metabolite profiling of nucleosides in esophageal adenocarcinoma” Rapid Communications in Mass Spectrometry. 2010, 24, 3057- 3062.

US Patent

D. Raftery, J. Bowers, Siwie, H.R. Baniasadi, Metabolite biomarkers for the detection of liver cancer, D. Raftery, J. Bowers, Siwie, H.R. Baniasadi. Date filed; May 21, 2013.